AI-optimized electrochemical aptasensors for stable, reproducible detection of neurodegenerative diseases, cancer, and coronavirus

AI-optimized electrochemical aptasensors are transforming diagnostic testing by offering high sensitivity, selectivity, and rapid response times. Leveraging data-driven AI techniques, these sensors provide a non-invasive, cost-effective alternative to traditional methods, with applications in detect...

Full description

Saved in:
Bibliographic Details
Main Authors: Amira Elsir Tayfour Ahmed, Th.S. Dhahi, Tahani A. Attia, Fawzia Awad Elhassan Ali, Mohamed Elshaikh Elobaid, Tijjani Adam, Subash C.B. Gopinath
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024173690
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841526186058973184
author Amira Elsir Tayfour Ahmed
Th.S. Dhahi
Tahani A. Attia
Fawzia Awad Elhassan Ali
Mohamed Elshaikh Elobaid
Tijjani Adam
Subash C.B. Gopinath
author_facet Amira Elsir Tayfour Ahmed
Th.S. Dhahi
Tahani A. Attia
Fawzia Awad Elhassan Ali
Mohamed Elshaikh Elobaid
Tijjani Adam
Subash C.B. Gopinath
author_sort Amira Elsir Tayfour Ahmed
collection DOAJ
description AI-optimized electrochemical aptasensors are transforming diagnostic testing by offering high sensitivity, selectivity, and rapid response times. Leveraging data-driven AI techniques, these sensors provide a non-invasive, cost-effective alternative to traditional methods, with applications in detecting molecular biomarkers for neurodegenerative diseases, cancer, and coronavirus. The performance metrics outlined in the comparative table illustrate the significant advancements enabled by AI integration. Sensitivity increases from 60 to 75 % in ordinary aptasensors to 85–95 %, while specificity improves from 70-80 % to 90–98 %. This enhanced performance allows for ultra-low detection limits, such as 10 fM for carcinoembryonic antigen (CEA) and 20 fM for mucin-1 (MUC1) using Electrochemical Impedance Spectroscopy (EIS), and 1 pM for prostate-specific antigen (PSA) with Differential Pulse Voltammetry (DPV). Similarly, Square Wave Voltammetry (SWV) and potentiometric sensors have detected alpha-fetoprotein (AFP) at 5 fM and epithelial cell adhesion molecule (EpCAM) at 100 fM, respectively. AI integration also enhances reproducibility, reduces false positives and negatives (from 15-20 % to 5–10 %), and significantly decreases response times (from 10-15 s to 2–3 s). These advancements improve data processing speeds (from 10 to 20 min per sample to 2–5 min) and calibration accuracy (<2 % margin of error compared to 5–10 %), while expanding application scope to multi-target biomarker detection. This review highlights how these advancements position AI-optimized electrochemical aptasensors as powerful tools for personalized treatment, point-of-care testing, and continuous health monitoring. Despite a higher cost ($500-$1,500/unit), their enhanced portability and diagnostic performance promise to revolutionize healthcare, environmental monitoring, and food safety, ultimately improving public health outcomes.
format Article
id doaj-art-375563e135b147cf9a58ff2c34930b30
institution Kabale University
issn 2405-8440
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj-art-375563e135b147cf9a58ff2c34930b302025-01-17T04:50:58ZengElsevierHeliyon2405-84402025-01-01111e41338AI-optimized electrochemical aptasensors for stable, reproducible detection of neurodegenerative diseases, cancer, and coronavirusAmira Elsir Tayfour Ahmed0Th.S. Dhahi1Tahani A. Attia2Fawzia Awad Elhassan Ali3Mohamed Elshaikh Elobaid4Tijjani Adam5Subash C.B. Gopinath6Department of Information System, College of Science &amp; Arts King Khalid University, Mohyel, Asser, Saudi ArabiaHealth and Medical Technicals College, Southern Technical University, Basrah, IraqDepartment of Computer Engineering, College of Computer Science and Engineering, University of Ha'il, Saudi Arabia; DEEE, Faculty of Engineering, University of Khartoum, SudanImam Abdulrahman Bin Faisal University, Applied College, Computer Department, Saudi ArabiaFaculty of Electronic Engineering &amp; Technology, Universiti Malaysia Perlis, 02600, Arau, Perlis, MalaysiaFaculty of Electronic Engineering &amp; Technology, Universiti Malaysia Perlis, 02600, Arau, Perlis, Malaysia; Institute of Nano Electronic Engineering, Universiti Malaysia Perlis, 01000, Kangar, Perlis, Malaysia; Micro System Technology, Centre of Excellence (CoE), Universiti Malaysia Perlis (UniMAP), Perlis, Malaysia; Corresponding author. Faculty of Electronic Engineering &amp; Technology, Universiti Malaysia Perlis, 02600, Arau, Perlis, Malaysia.Center for Global Health Research, Saveetha Medical College &amp; Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Thandalam, Chennai, 602 105, Tamil Nadu, India; Faculty of Chemical Engineering &amp; Technology, Universiti Malaysia Perlis (UniMAP), 02600, Arau, Perlis, MalaysiaAI-optimized electrochemical aptasensors are transforming diagnostic testing by offering high sensitivity, selectivity, and rapid response times. Leveraging data-driven AI techniques, these sensors provide a non-invasive, cost-effective alternative to traditional methods, with applications in detecting molecular biomarkers for neurodegenerative diseases, cancer, and coronavirus. The performance metrics outlined in the comparative table illustrate the significant advancements enabled by AI integration. Sensitivity increases from 60 to 75 % in ordinary aptasensors to 85–95 %, while specificity improves from 70-80 % to 90–98 %. This enhanced performance allows for ultra-low detection limits, such as 10 fM for carcinoembryonic antigen (CEA) and 20 fM for mucin-1 (MUC1) using Electrochemical Impedance Spectroscopy (EIS), and 1 pM for prostate-specific antigen (PSA) with Differential Pulse Voltammetry (DPV). Similarly, Square Wave Voltammetry (SWV) and potentiometric sensors have detected alpha-fetoprotein (AFP) at 5 fM and epithelial cell adhesion molecule (EpCAM) at 100 fM, respectively. AI integration also enhances reproducibility, reduces false positives and negatives (from 15-20 % to 5–10 %), and significantly decreases response times (from 10-15 s to 2–3 s). These advancements improve data processing speeds (from 10 to 20 min per sample to 2–5 min) and calibration accuracy (<2 % margin of error compared to 5–10 %), while expanding application scope to multi-target biomarker detection. This review highlights how these advancements position AI-optimized electrochemical aptasensors as powerful tools for personalized treatment, point-of-care testing, and continuous health monitoring. Despite a higher cost ($500-$1,500/unit), their enhanced portability and diagnostic performance promise to revolutionize healthcare, environmental monitoring, and food safety, ultimately improving public health outcomes.http://www.sciencedirect.com/science/article/pii/S2405844024173690AIAptasensorsElectrochemicalCoronavirusNeurodegenerativeCancer
spellingShingle Amira Elsir Tayfour Ahmed
Th.S. Dhahi
Tahani A. Attia
Fawzia Awad Elhassan Ali
Mohamed Elshaikh Elobaid
Tijjani Adam
Subash C.B. Gopinath
AI-optimized electrochemical aptasensors for stable, reproducible detection of neurodegenerative diseases, cancer, and coronavirus
Heliyon
AI
Aptasensors
Electrochemical
Coronavirus
Neurodegenerative
Cancer
title AI-optimized electrochemical aptasensors for stable, reproducible detection of neurodegenerative diseases, cancer, and coronavirus
title_full AI-optimized electrochemical aptasensors for stable, reproducible detection of neurodegenerative diseases, cancer, and coronavirus
title_fullStr AI-optimized electrochemical aptasensors for stable, reproducible detection of neurodegenerative diseases, cancer, and coronavirus
title_full_unstemmed AI-optimized electrochemical aptasensors for stable, reproducible detection of neurodegenerative diseases, cancer, and coronavirus
title_short AI-optimized electrochemical aptasensors for stable, reproducible detection of neurodegenerative diseases, cancer, and coronavirus
title_sort ai optimized electrochemical aptasensors for stable reproducible detection of neurodegenerative diseases cancer and coronavirus
topic AI
Aptasensors
Electrochemical
Coronavirus
Neurodegenerative
Cancer
url http://www.sciencedirect.com/science/article/pii/S2405844024173690
work_keys_str_mv AT amiraelsirtayfourahmed aioptimizedelectrochemicalaptasensorsforstablereproducibledetectionofneurodegenerativediseasescancerandcoronavirus
AT thsdhahi aioptimizedelectrochemicalaptasensorsforstablereproducibledetectionofneurodegenerativediseasescancerandcoronavirus
AT tahaniaattia aioptimizedelectrochemicalaptasensorsforstablereproducibledetectionofneurodegenerativediseasescancerandcoronavirus
AT fawziaawadelhassanali aioptimizedelectrochemicalaptasensorsforstablereproducibledetectionofneurodegenerativediseasescancerandcoronavirus
AT mohamedelshaikhelobaid aioptimizedelectrochemicalaptasensorsforstablereproducibledetectionofneurodegenerativediseasescancerandcoronavirus
AT tijjaniadam aioptimizedelectrochemicalaptasensorsforstablereproducibledetectionofneurodegenerativediseasescancerandcoronavirus
AT subashcbgopinath aioptimizedelectrochemicalaptasensorsforstablereproducibledetectionofneurodegenerativediseasescancerandcoronavirus